In addition, structural insights could assist in determining whether the PGC-1α and ERRα proteins interact with specific oncogenes or tumor suppressors and thus play different roles in metabolic plasticity favoring drug resistance or decreasing cancer progression. This evidence concerns the gene PPARGC1A and neoplasm.